Effect of cyclosporine on immune responses in submaxillary lymph nodes of pituitary-grafted rats

NeuroSignals

Volumn 5, Issue 6, 1996, Pages 334-342

  Arce, Agustín ^a   Castrillón, Patricia O ^a   Della Maggiore, Valeria ^b   Cardinali, Daniel P ^b   Esquifino, Ana I ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cyclosporine; Hyperprolactinemia; Lymphocyte proliferation; Lymphoid tissue; Natural killer activity; Neuroimmunomodulation

Indexed keywords

CONCANAVALIN A; CYCLOSPORIN; FREUND ADJUVANT; LIPOPOLYSACCHARIDE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; HYPERPROLACTINEMIA; HYPOPHYSIS GRAFT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CAPSULE; LYMPH NODE; MALE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; RAT;

AGING; ANIMALS; ANIMALS, NEWBORN; CELL DIVISION; CONCANAVALIN A; CYCLOSPORINE; FREUND'S ADJUVANT; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPH NODES; MALE; PITUITARY GLAND; RATS; RATS, WISTAR;

EID: 0030484654     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000109206     Document Type: Article

References (42)

1. Bcrczi I: The immune system and its function; in Berczi I (ed): Pituitary Function and Immunity. Boca Raton, CRC Press, 1986, pp 1-10.
2. Nicoletti I, Gerli R, Orlandi S, Mi-gliorati G, Rambotti P, Riccardi C: Defective natural killer activity in puerperal hyperprolactinemia. J Re-prod Immunol 1989:15:113-118.
3. Gala RG, Shcvach EM: Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proc Soc Exp Biol Med 1993;204:224-230.
4. Russell DH, Mills KT, Talamantes FJ, Bern HA: Neonatal administration of prolactin antiscrum alters the developmental pattern of T and B lymphocytes in the thymus and spleen of BALB/c female mice. Proc Natl Acad Sci USA 1988;85:7404-7408.
5. Fabris N: Neuroendocrine regulation of immunity; in Maestroni GJM. Conti A, Reiter RJ (eds): Advances in Pineal Research. London, Libbey, 1994, vol 7, pp 41-56.
6. Fabris N, Pierpaoli W, Sorkin E: Hormones and the immunological capacity. III. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin Exp Immunol 1971;9:209.
7. Roszman TL, Brooks WH: Signaling pathways of the neuroendocrine-immune network; in Blalock JE (ed): Ncuroimmunocndocrinology. Basel. Karger. 1992, pp 170-180.
8. Adler RA: The anterior pituitary-graftcd rat: A valid model of chronic hyperprolactinemia. Endocr Rev 1986;7:302-313.
9. Bcrczi I, Nagy E: Effects of hypo-physectomy on immune function; in Ader R. Fcltcn DL, Cohen N (eds): Psychoncuroimmunology, cd 2. New York, Academic Press, 1991. pp 339-350.
10. Nagy E, Bcrczi I, Friescn HG: Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol 1983;102:351-357.
11. Murphy WJ, Durum SK, Anver MR, Longo DL: Immunologic and hematologic effects of neuroendocrine hormones. Studies on dwarf mice. J Immunol 1992; 148:3799-3805.
12. Esquifino AI, Villamia MA, Szary A, Yau J, Bartke A: Ectopic pituitary transplants restore immunocompétence in Ames dwarf mice. Acta Endocrinol 1991;125:67-72.
13. Villamia MA, Szary A, Bartke A, Esquifino AI: Changes in lymphoid organs of Ames dwarf mice after treatment with growth hormone, prolactin or ectopic pituitary transplants. J Clin Invest 1992; 15:587-595.
14. Bcmton EW, Mcllzcr MS, Holaday JW: Suppression of macrophage activation and T-lymphocyte function in hypoprolactincmic mice. Science 1988;239:404.
15. Gerli R, Rambotti P, Nicoletti I, Orlandi S, Migliorati G, Riccardi C: Reduced number of natural killer cells in patients with pathological hypcrprolactincmia. Clin Exp Immunol 1986:64:399.
16. Ramirez G, Narvante J, Bittle PA, Ayers-Chastain C, Dean SE: Cyclo-sporine-induced alterations in the hypothalamic hypophyseal gonadal axis in transplanted patients. Nephron 1991;58:27-32.
17. Wilner ML, Ettenger RB, Koyle MA, Rosenthal JT: The effect of hyperprolactinemia alone and in combination with cyclosporine on allograft rejection. Transplantation 1990;49:264-268.
18. Russell DH, Kibler R, Matrisian L, Larson DF, Paulos B, Magin BE: Prolactin receptors on human T and B lymphocytes. Antagonism of prolactin binding by cyclosporine. J Immunol 1985;134:3027-3031.
19. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C: Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sei LISA 1986; 83:2599.
20. Esquifmo AI, Moreno ML, Arce A, Agrasal C, Pcrez-Diaz J, Villanúa MA: Effects of cyclosporine at the hypothalamic-pituitary axis in pitu-itary-grafted young female rats. J Endocrinol 1995;144:159-164.
21. Tresguerres JAF, Esquifmo AI, López Calderón: Effects of estradiol benzoate and castration on LH in experimental hypcrprolactinemia. J Steroid Biochem 1983;19:447-453.
22. Tresquerres JAF, Esquifmo AI: Dissociation in the regulation of luteinizing hormone and follicle stimulating hormone in a hyperprolactin-emic rat model: Interrelationships between gonadotropin and prolactin control. J Endocrinol 198l;90:41-51.
23. Grabstein K: Cell-mediated cytolytic responses; in Mischell BB, Shiigi SM (eds): Selected Methods in Cellular Immunology. New York, Freeman, 1980, pp 124-127.
24. Arce A: Papel de la prolactina y la inervación autonómica en los efectos de la ciclosporina sobre la respuesta inmunológica de los ganglios linfáticos submaxilares; doctoral thesis, Universidad Autónoma de Madrid, 1994.
25. Bemton E, Bryant H, Holaday J, Dave J: Prolactin and prolactin sc-cretagogues reverse immunosuppression in mice treated with cys-teamine, glucocorticoids, or cyclos-porin-A. Brain Behav Immun 1992; 6:394-408.
26. Carrier M, Russell DH, Wild JC, Emery RW, Copeland JG: Prolactin as marker of rejection in human heart transplantation. J Heart Transplant 1987;6:290-292.
27. Cosson C, Myara I, Guillerman R, Amrein C, Dreyfus G, Moatti N: Serum prolactin as a rejection marker in heart transplantation. Clin Chem 1989;35:492-499.
28. Cross RJ, Campbell JC, Roszman TL: Potentiation of antibody responsiveness after the transplantation of a syngenic pituitary graft. J Neuroimmunol 1989;25:29-35.
29. Matera L, Cesano A, Veglia F, Muc-cioli G: Effect of prolactin on human natural killer activity. Ann NY Acad Sci 1989;490:396-398.
30. Borel J: Comparative study of in vivo and in vitro drug effects on cell mediated cytotoxicity. Immunology 1977;31:631-634.
31. Borel J: Cyclosporine: Historical perspectives. Transplant Proc 1983; 15:2219-2229.
32. Kosugi A, Sharrow SO, Sherearer GM: Effect of cyclosporin A on lymphopoiesis. I. Absence of mature cells in thymus and periphery of bone marrow transplanted mice treated with cyclosporin A. J Immunol 1989;142:3026-3032.
33. Cammisuli S: The effect of Cyclosporin A on cell interactions within the immune system; in White DJG (ed): Cyclosporin A. Amsterdam, Elsevier, 1982, pp 243-259.
34. Parker D, Drossier K, Turk JL: Kinetics of the effect of a single dose of cyclosporin A on antibody and cell-mediated immune response in the guinea pig. Int J Immunopharmacol 1984;6:67-74.
35. Matera L, Muccioli G, Cesano A: Prolactin receptors on large granular lymphocytes: Dual regulation by cyclosporin A. Brain Behav Immun 1988;2:1-10.
36. Villanua MA, Stegcr RW, Szary A, Esquifmo AI, Bartke A: Cyclosporine treatment in hyperprolactin-cmic male rats. II. Effects at hypothalamic level. Prog Neuroendocrin-Immunol 1992;5:52-61.
37. Villanua MA, Szary A, Bartke A, Esquifino AI: Cyclosporine treatment in hyperprolactinemic male rats. I. Effects on lymphoid organs and prolactin. Prog Neurocndocrin-Immunol 1992;5:40-51.
38. Esquifino AI, Stegcr RW, Bartke A, Amador A, Chandrashekar V: Effects of estrogen and ectopic pituitary transplants on the responsiveness of pituitary prolactin release to LHRH and dopamine. J Neuroen-docrinol 1991;2:145-149.
39. Esquifino AI, Agrasal A, Steger RW, Femandez-Ruiz JJ, Ramos JA, Ce-beira M, Bartke A: Catecholaminer-gic control of plasma growth hormone and thyrotropin levels in hy-pophysectomized rats bearing ectopic pituitary transplants. Life Sci 1987;41:1043-1050.
40. Moreno ML, Arce A, Villanua MA, Esquifino AI: Cyclosporine effect on in vitro responsiveness of anterior pituitary hormone release to dopamine and thyrotropin releasing hormone in young female rats. J Ncu-roendocrinol 1995;7:765-774.
41. Agrasal A, Femandez-Ruiz JJ, Ce-beira M, Ramos JA, Tresguerres JAF, Esquifino AI: Possible role of dopaminergic, noradrenergic, and serotoninergic neurons on hyperprolactinemia induced changes in growth hormone secretion. Biogenic Amines 1988;5:397-404.
42. Agrasal A, Cebeira M, Femandez-Ruiz JJ, Ramos JA, Tresguerres JAF, Esquifino AI: Possible role of hypothalamic biogenic amines on hyperprolactinemia induced changes in thyrotropin hormone secretion. Biogenic Amines 1989;6: 315-321.